ArticleVeterinary world2025
Egg yolk-derived phosvitin as a natural chelator:
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Mercury (hydrargyrum, Hg) exposure poses significant risks to human, animal, and environmental health due to its persistence and toxicity. Conventional chelating agents, though effective, are limited by adverse side effects and reduced efficacy in chronic exposure. Phosvitin (PSV), a highly phosphorylated protein from egg yolk with strong metal-binding capacity, offers potential as a natural detoxifying agent. This study aimed to evaluate, for the first time Materials and Methods: PSV was isolated from Isa Brown hen egg yolks through ethanol precipitation and characterized for purity and antioxidant activity using Fourier Transform Infrared Spectroscopy, Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis, Kjeldahl analysis, and the 2,2-diphenyl-1-picrylhydrazyl assay. Twenty-five male rats were exposed to Hg-contaminated fish feed (0.17 ppm for 14 days) and subsequently treated with commercial or isolated PSV at 10, 20, or 30 ppm for 4 weeks. Hematological indices, liver and kidney histopathology, and Hg accumulation in brain tissue were assessed. Data were analyzed using R software (v4.4.0), with p < 0.05 considered statistically significant. Results: The isolated PSV exhibited moderate antioxidant activity, comparable to that of commercial standards, with a purity of 51.68%. Hg exposure significantly increased white blood cell (WBC) and basophil counts, indicating immune activation. PSV administration, particularly at 20 ppm, markedly reduced WBC and basophil levels, reflecting immunomodulatory activity. Histopathological analysis revealed reduced hepatic necrosis and milder liver damage in treated groups, with modest improvement in renal structure, though not statistically significant. Brain analysis showed decreased Hg accumulation in the 10 and 20 ppm PSV groups, while the 30 ppm group exhibited inconsistent effects. Conclusion: Egg yolk-derived PSV, especially at 20 ppm, effectively mitigated Hg-induced hematological, hepatic, and neural toxicity, supporting its role as a safe natural chelator. These findings highlight its potential as a dietary intervention in Hg-exposed populations. Optimization of extraction methods, larger-scale studies, and long-term safety assessments are needed to advance its translational application in toxicology and public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.